This shareable PDF can be hosted on any platform or network and is fully compliant with publisher copyright.
This publication has not yet been explained in plain language by the author(s). However, you can still read the publication.
If you are one of the authors, claim this publication so you can create a plain language summary to help more people find, understand and use it.
This page is a summary of: Dose to Pelvic Bone Marrow Defined with FDG-PET Predicts for Hematologic Nadirs in Anal Cancer Patients Treated with Concurrent Chemo-radiation, Cancer Investigation, June 2018, Taylor & Francis,
DOI: 10.1080/07357907.2018.1479413.
You can read the full text:
The following have contributed to this page
Cancer Discovery
Patients with cancer have a higher risk of infection and death by COVID-19 than healthy people. Moreover, the pandemic has disrupted cancer care, from screening and diagnosis to therapy. In this ar...
F1000Research
This study shows a remarkable improvement of about 95.7% in resolving the symptoms of excessive sweating after the minimally invasive surgery. However, the rate of compensatory sweating on other pa...
Frontiers in Oncology
Immunotherapy is a major breakthrough in the treatment of cancer in recent years. Immune checkpoint inhibitors (ICIs) including programmed death-ligand 1 (PD-L1)/ programmed death-1 (PD-1) and cyto...
